Ligne de temps
Yusuke Shimakawa
Chercheur(euse) Permanent(e)
01 avr. 2024
publication
Development and evaluation of a simple treatment eligibility score (HEPSANET) to decentralise hepatitis B care in Africa: a cross-sectional study.
Lire plus26 janv. 2024
publication
Simplified Criteria to Assess Long-Term Antiviral Treatment Indication in Chronic HBV-Infected Pregnant Women in Cambodia.
Lire plus01 janv. 2024
publication
Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis.
Lire plus01 sept. 2023
publication
A global research priority agenda to advance public health responses to fatty liver disease.
Lire plus01 sept. 2023
publication
Poor disease knowledge among people living with hepatitis B in The Gambia and Tanzania.
Lire plus01 sept. 2023
publication
Clinical characteristics and outcomes of patients with cirrhosis and hepatocellular carcinoma in The Gambia, west Africa: a prospective cohort study.
Lire plus01 juil. 2023
publication
Impact and cost-effectiveness of hepatitis B virus prophylaxis in pregnancy: a dynamic simulation modelling study.
Lire plus01 juil. 2023
publication
Informing a target product profile for rapid tests to identify HBV-infected pregnant women with high viral loads: a discrete choice experiment with African healthcare workers
Lire plus21 juin 2023
publication
Enjeux et difficultés de l’accès aux traitements pour la prise en charge de l’hépatite B chronique à Madagascar : étude qualitative auprès des soignants et personnes atteintes
Lire plus01 mai 2023
publication
Risk of early horizontal transmission of hepatitis B virus in children of uninfected mothers in sub-Saharan Africa: a systematic review and meta-analysis.
Lire plus03 avr. 2023
publication
Hepatitis B in Africa Collaborative Network: cohort profile and analysis of baseline data.
Lire plus26 janv. 2023
20 janv. 2023
publication
Cost-effectiveness of different monitoring strategies in a screening and treatment programme for hepatitis B in The Gambia.
Lire plus03 janv. 2023
publication
Systematic review and individual-patient-data meta-analysis of non-invasive fibrosis markers for chronic hepatitis B in Africa.
Lire plus12 nov. 2022
publication
Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa.
Lire plus01 oct. 2022
publication
HBV continuum of care using community- and hospital-based screening interventions in Senegal: Results from the PROLIFICA programme.
Lire plus08 sept. 2022
publication
Hepatitis B surface antigen prevalence and the rates of mother-to-child transmission of hepatitis B virus after the introduction of infant vaccination programs in South East Asia and Western Pacific regions: a systematic review.
Lire plus09 août 2022
publication
Prevalence of occult hepatitis B virus infection in adults: a systematic review and meta-analysis.
Lire plus01 août 2022
publication
Meta-analysis: risk of hepatitis C virus infection associated with hospital-based invasive procedures.
Lire plus10 juin 2022
publication
Rapid Point-of-Care Test for Hepatitis B Core-Related Antigen to Diagnose High Viral Load in Resource-Limited Settings.
Lire plus01 avr. 2022
publication
Screening for Hepatitis B in partners and children of women positive for surface antigen, Burkina Faso.
Lire plus25 mars 2022
17 févr. 2022
publication
Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study.
Lire plus01 janv. 2022
publication
Prevalence of hepatitis B, C, and D virus infection in Haiti: A systematic review and meta-analysis.
Lire plus17 déc. 2021
publication
Hepatitis B in Senegal: A Successful Infant Vaccination Program but Urgent Need to Scale Up Screening and Treatment (ANRS 12356 AmBASS survey).
Lire plus22 nov. 2021
01 oct. 2021
publication
Including the voice of people living with viral hepatitis: lessons learned from Japan to accelerate progress towards global hepatitis elimination.
Lire plus05 juil. 2021
publication
Cost-effectiveness of adding a birth dose of hepatitis B vaccine in the Dafra district of the Hauts-Bassins Region in Burkina Faso (NéoVac Study).
Lire plus23 juin 2021
publication
Prevalence and Clinical Significance of Occult Hepatitis B Infection in The Gambia, West Africa.
Lire plus14 juin 2021
publication
Maternal Age at First Childbirth and Geographical Variation in Hepatitis B Virus Prevalence in Cameroon: Important Role of Mother-to-Child Transmission.
Lire plus01 juin 2021
publication
Impact of Introducing Hepatitis B Birth Dose Vaccines into the Infant Immunization Program in Burkina Faso: Study Protocol for a Stepped Wedge Cluster Randomized Trial (NéoVac Study).
Lire plus18 mai 2021
publication
The Costs of Introducing the Hepatitis B Birth Dose Vaccine into the National Immunization Programme in Senegal (NéoVac Study).
Lire plus01 mai 2021
publication
Analytical validation of hepatitis B core‐related antigen (HBcrAg) using dried blood spots (DBS)
Lire plus07 avr. 2021
publication
Development and clinical validation of loop-mediated isothermal amplification (LAMP) assay to diagnose high HBV DNA levels in resource-limited settings.
Lire plus01 avr. 2021
22 mars 2021
publication
Clinical utility of quantifying hepatitis B surface antigen in African patients with chronic hepatitis B.
Lire plus28 févr. 2021
publication
Epidemiological projections of viral-induced hepatocellular carcinoma in the perspective of WHO global hepatitis elimination.
Lire plus17 déc. 2020
publication
Assessment and Simplification of Treatment Eligibility Among Patients With Chronic Hepatitis B Infection in Vietnam.
Lire plus01 oct. 2020
publication
Hepatitis B virus preS2Δ38-55 variants: A newly identified risk factor for hepatocellular carcinoma.
Lire plus17 sept. 2020
publication
Effect of the COVID-19 pandemic on viral hepatitis services in sub-Saharan Africa.
Lire plus25 août 2020
publication
Reply to: “Validation of the TREAT-B score for hepatitis B treatment eligibility in a large Asian cohort: TREAT-B improves with age”.
Lire plus14 août 2020
publication
Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis.
Lire plus14 août 2020
publication
Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis.
Lire plus11 juin 2020
publication
Coverage and Timeliness of Birth Dose Vaccination in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
Lire plus19 mai 2020
news
Invitation to Submit: Special Issue “Timely Administration of the Hepatitis B Birth Dose Vaccine”
Lire plus29 avr. 2020
publication
Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual Participants.
Lire plus01 mars 2020
publication
Limited Awareness of Hepatitis B but Widespread Recognition of Its Sequelae in Rural Senegal: A Qualitative Study.
Lire plus01 mars 2020
01 janv. 2020
publication
Time matters: Point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in England.
Lire plus28 nov. 2019
publication
In-field evaluation of Xpert® HCV viral load Fingerstick assay in people who inject drugs in Tanzania.
Lire plus07 nov. 2019
publication
Mother-to-child transmission of hepatitis B: What more needs to be done to eliminate it around the world?
Lire plus01 oct. 2019
publication
Performance of two simplified HBV treatment criteria (TREAT-B score and WHO guidelines) in Burkina Faso, West Africa.
Lire plus17 mai 2019
publication
Hepatitis B Core-related Antigen: An Alternative to Hepatitis B Virus DNA to Assess Treatment Eligibility in Africa.
Lire plus01 mai 2019
publication
[Prevention of liver fibrosis and liver cancer linked to hepatitis B virus in Africa: the Prolifica study].
Lire plus11 avr. 2019
publication
Clinical utility of TREAT-B score in African and non-African HBV-infected patients living in Europe.
Lire plus05 avr. 2019
publication
Indication for treatment and severity of disease in treatment-naive patients with chronic hepatitis B virus infection.
Lire plus03 févr. 2019
publication
High prevalence and poor linkage to care of transfusion-transmitted infections among blood donors in Dar-es-Salaam, Tanzania.
Lire plus01 févr. 2019
publication
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.
Lire plus22 sept. 2018
03 juil. 2018
publication
The hepatitis C cascade of care in people who inject drugs in Dar es Salaam, Tanzania.
Lire plus18 juin 2018
publication
Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa.
Lire plus01 juin 2018
publication
Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C-infected Egyptian cohort: A comparative analysis.
Lire plus01 juin 2018
publication
Letter: concordance of SVR4 and SVR12 following direct-acting anti-viral treatment in Egypt.
Lire plus31 mai 2018
publication
Poor Sensitivity of Commercial Rapid Diagnostic Tests for Hepatitis B e Antigen in Senegal, West Africa.
Lire plus08 mai 2018
publication
Risk of hepatitis B virus reactivation with direct-acting antivirals against hepatitis C virus: A cohort study from Egypt and meta-analysis of published data.
Lire plus03 avr. 2018
publication
Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus.
Lire plus07 mars 2018
event
“Genome-wide association study on Viral hepatitis C and hepatocellular carcinoma” with Prof. Yasuhito Tanaka – Infection & Epidemiology department
Lire plus07 mars 2018
publication
Screening strategies to prevent mother-to-child transmission of hepatitis B in sub-Saharan Africa.
Lire plus07 mars 2018
14 sept. 2017
publication
Clinical utility of HCV core antigen detection and quantification using serum samples and dried blood spots in people who inject drugs in Dar-es-Salaam, Tanzania.
Lire plus04 août 2017
publication
Prevalence of chronic hepatitis B virus infection and infrastructure for its diagnosis in Madagascar: implication for the WHO’s elimination strategy.
Lire plus21 juin 2017
14 juin 2017
publication
Hepatitis B testing and treatment in HIV patients in The Gambia-Compliance with international guidelines and clinical outcomes.
Lire plus01 juin 2017
01 janv. 2017
publication
Community-based screening and treatment for chronic hepatitis B in sub-Saharan Africa – Authors’ reply.
Lire plus24 oct. 2016
publication
Barriers to Linkage to Care for Hepatitis B Virus Infection: A Qualitative Analysis in Burkina Faso, West Africa.
Lire plus15 sept. 2016
publication
Systematic review with meta-analysis: the risk of mother-to-child transmission of hepatitis B virus infection in sub-Saharan Africa.
Lire plus01 août 2016
publication
Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study.
Lire plus01 août 2016
publication
Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis.
Lire plus07 juil. 2016
publication
Diagnostic accuracy of the γ-glutamyl transpeptidase to platelet ratio to predict liver fibrosis in Egyptian patients with HCV genotype 4.
Lire plus16 mai 2016
publication
Barriers to timely administration of birth dose vaccines in The Gambia, West Africa.
Lire plus26 févr. 2016
publication
Diagnostic accuracy of the gamma-glutamyl transpeptidase to platelet ratio (GPR) using transient elastography as a reference.
Lire plus26 févr. 2016
publication
Excess mortality rate associated with hepatitis C virus infection: A community-based cohort study in rural Egypt.
Lire plus29 janv. 2016
01 janv. 2016
01 déc. 2015
publication
Hepatitis E virus infection and acute-on-chronic liver failure in West Africa: a case-control study from The Gambia.
Lire plus01 oct. 2015
publication
Birth order and risk of hepatocellular carcinoma in chronic carriers of hepatitis B virus: a case-control study in The Gambia.
Lire plus25 sept. 2015
14 sept. 2015
project
ANRS 12332 HepNile: Evaluation of “Real Life” Efficacy and Safety of antiviral treatments including new Direct Antiviral Agents among patients treated for Chronic Hepatitis C at Egyptian National Treatment Centres
Lire plus16 juil. 2015
publication
Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia.
Lire plus24 juin 2015
publication
The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa.
Lire plus11 mai 2015
01 avr. 2015
publication
Validation of rapid point-of-care (POC) tests for detection of hepatitis B surface antigen in field and laboratory settings in the Gambia, Western Africa.
Lire plus05 sept. 2014
publication
The prevalence and burden of symptoms in patients with chronic liver diseases in The Gambia, West Africa.
Lire plus25 août 2014
publication
Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West Africans.
Lire plus01 juin 2014
publication
Population-based interventions to reduce the public health burden related with hepatitis B virus infection in the gambia, west Africa.
Lire plus30 mai 2014
publication
The association between maternal hepatitis B e antigen status, as a proxy for perinatal transmission, and the risk of hepatitis B e antigenaemia in Gambian children.
Lire plus01 mars 2014
publication
Commentary: how long does one need to fast before a Fibroscan examination? Authors’ reply.
Lire plus01 janv. 2014
publication
Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The Gambia.
Lire plus19 juil. 2013
publication
Association of early age at establishment of chronic hepatitis B infection with persistent viral replication, liver cirrhosis and hepatocellular carcinoma: a systematic review.
Lire plus01 févr. 2013
22 févr. 2010